UnitedHealth Group (UNH) Hits New Lifetime High

Trade-Ideas LLC identified UnitedHealth Group (UNH) as a new lifetime high candidate
By TheStreet Wire ,

Trade-Ideas LLC identified

UnitedHealth Group

(

UNH

) as a new lifetime high candidate. In addition to specific proprietary factors, Trade-Ideas identified UnitedHealth Group as such a stock due to the following factors:

  • UNH has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $560.3 million.
  • UNH has traded 92,716 shares today.
  • UNH is trading at a new lifetime high.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in UNH with the Ticky from Trade-Ideas. See the FREE profile for UNH NOW at Trade-Ideas

More details on UNH:

UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. The stock currently has a dividend yield of 1.8%. UNH has a PE ratio of 23. Currently there are 17 analysts that rate UnitedHealth Group a buy, 1 analyst rates it a sell, and 1 rates it a hold.

The average volume for UnitedHealth Group has been 3.3 million shares per day over the past 30 days. UnitedHealth Group has a market cap of $134.4 billion and is part of the health care sector and health services industry. The stock has a beta of 0.64 and a short float of 1.1% with 2.16 days to cover. Shares are up 19.6% year-to-date as of the close of trading on Monday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

TheStreetRatings.com

Analysis:

TheStreet Quant Ratings

rates UnitedHealth Group as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, growth in earnings per share, increase in net income, solid stock price performance and good cash flow from operations. We feel its strengths outweigh the fact that the company shows low profit margins.

Highlights from the ratings report include:

  • The revenue growth came in higher than the industry average of 8.5%. Since the same quarter one year prior, revenues rose by 24.5%. Growth in the company's revenue appears to have helped boost the earnings per share.
  • UNITEDHEALTH GROUP INC has improved earnings per share by 14.4% in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past two years. We feel that this trend should continue. During the past fiscal year, UNITEDHEALTH GROUP INC increased its bottom line by earning $6.01 versus $5.70 in the prior year. This year, the market expects an improvement in earnings ($7.89 versus $6.01).
  • The net income growth from the same quarter one year ago has exceeded that of the S&P 500, but is less than that of the Health Care Providers & Services industry average. The net income increased by 14.0% when compared to the same quarter one year prior, going from $1,413.00 million to $1,611.00 million.
  • The stock has not only risen over the past year, it has done so at a faster pace than the S&P 500, reflecting the earnings growth and other positive factors similar to those we have cited here. The stock's price rise over the last year has driven it to a level which is somewhat expensive compared to the rest of its industry. We feel, however, that other strengths this company displays justify these higher price levels.
  • Net operating cash flow has slightly increased to $2,318.00 million or 2.15% when compared to the same quarter last year. Despite an increase in cash flow, UNITEDHEALTH GROUP INC's cash flow growth rate is still lower than the industry average growth rate of 19.82%.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Loading ...